Articles published by Sarepta Therapeutics, Inc.
![](https://mms.businesswire.com/media/20240807747128/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20240731742607/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240729073260/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240628469623/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240620640445/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20240531542977/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240503391992/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20240501857942/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20240430608897/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 30, 2024
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240424210170/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240329870657/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 29, 2024
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240304022051/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240229124069/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 29, 2024
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240229172355/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20240228046825/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20240221930450/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results
February 21, 2024
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240216425436/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20240131729690/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 31, 2024
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240129970075/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20240116971158/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20240108854944/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2023 Net Product Revenue
January 08, 2024
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20240102402211/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20231229111409/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 29, 2023
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20231222229596/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20231130376976/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 30, 2023
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20231102269533/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics to Present at the UBS Biopharma Conference
November 02, 2023
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20231101211984/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics Announces Third Quarter 2023 Financial Results and Recent Corporate Developments
November 01, 2023
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20231031312403/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 31, 2023
Via Business Wire
Tickers
SRPT
![](https://mms.businesswire.com/media/20231030875867/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20231025578048/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Via Business Wire
Tickers
SRPT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.